Breddin K
Z Gesamte Inn Med. 1984 May 15;39(10):234-41.
The primary haemostasis begins with the activation of the thrombocytes. This activation is induced by nucleotides, by the haemostasis-activating factor existing in most tissues, by thrombin, collagen, adrenaline, serotonin and other activators. The activation is accompanied by an increased inclination of the thrombocytes to adhesion and aggregation. Morphologically activated platelets show appendices and become ball-shaped. These processes are reversible in vivo and in vitro. Medicaments inhibiting the function of the platelets were above all selected on account of their effect inhibiting the aggregation and were clinically tested. It is uncertain in what respect inhibition of the aggregation and inhibition of the thrombosis correlate. A technique for the judgement of the inhibition of the tissue extract-induced change of the form of thrombocytes is demonstrated as a method for the measurement of the activation of the platelets. Acetylsalicylic acid influences the aggregation of platelets by inhibition of the cyclooxygenase in the thrombocytes. This leads to an inhibition of the thromboxane synthesis in the platelets which lasts for days, since it is irreversible. The spontaneous change of the form of the thrombocytes and the tissue extract-induced change of the form of the platelets by acetylsalicylic acid are, however, influenced only for the duration of 6-10 hours.
初级止血始于血小板的激活。这种激活由核苷酸、大多数组织中存在的止血激活因子、凝血酶、胶原蛋白、肾上腺素、血清素及其他激活剂诱导。激活过程伴随着血小板黏附和聚集倾向的增加。形态学上激活的血小板会出现伪足并变成球形。这些过程在体内和体外都是可逆的。抑制血小板功能的药物首先因其抑制聚集的作用而被选用,并进行了临床试验。聚集抑制与血栓形成抑制在哪些方面相关尚不确定。一种判断组织提取物诱导的血小板形态变化抑制作用的技术被证明是一种测量血小板激活的方法。乙酰水杨酸通过抑制血小板中的环氧化酶来影响血小板的聚集。这导致血小板中血栓素的合成受到抑制,且这种抑制会持续数天,因为它是不可逆的。然而,乙酰水杨酸对血小板形态的自发变化以及组织提取物诱导的血小板形态变化的影响仅持续6 - 10小时。